BiotechTube

Julphar Insulin R (soluble human insulin, biosimilar) + Huminsulin® Normal (soluble human insulin, reference)

Phase 1Completed
0 watching 0 views this week💤 Quiet
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Diabetes Mellitus

Conditions

Diabetes Mellitus

Trial Timeline

Dec 1, 2014 → Feb 1, 2015

NCT ID
NCT02634515

About Julphar Insulin R (soluble human insulin, biosimilar) + Huminsulin® Normal (soluble human insulin, reference)

Julphar Insulin R (soluble human insulin, biosimilar) + Huminsulin® Normal (soluble human insulin, reference) is a phase 1 stage product being developed by Gulf Pharmaceutical Industries for Diabetes Mellitus. The current trial status is completed. This product is registered under clinical trial identifier NCT02634515. Target conditions include Diabetes Mellitus.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02634515Phase 1Completed

Competing Products

20 competing products in Diabetes Mellitus

See all competitors
ProductCompanyStageHype Score
add-on pioglitazone + add-on sulphonylureaAMD BiotechApproved
77
MKP10241 + PlaceboMankind PharmaPhase 2
52
Daily injection of KBP/placebo for up to 28 daysEli LillyPhase 1
33
LY3209590 + Insulin DegludecEli LillyPhase 1
33
AC2993Eli LillyPhase 3
77
LY3209590 + PlaceboEli LillyPhase 1
33
Insulin Lispro Protamine Suspension + Insulin GlargineEli LillyPhase 3
77
LY2963016 + LantusEli LillyPhase 1
33
Empagliflozin + Other SGLT2 inhibitors + Other non-insulin GLDsEli LillyPre-clinical
23
Insulin Lispro Mix25 + Insulin Lispro Mix50Eli LillyApproved
85
Nasal Glucagon + Intramuscular GlucagonEli LillyPhase 3
77
Retatrutide + PlaceboEli LillyPhase 1
33
AG019 - Low Dose + Teplizumab + Placebo-AG019 + Placebo-Teplizumab + AG019 - High Dose + AG019 - High DosePrecigenPhase 1/2
36
LY4057996 SC + LY4057996 IV + Placebo SC + Placebo IV + Degludec SC + Lispro SC + Degludec IV + Pre-study basal insulin SCEli LillyPhase 1
33
Placebo + LinagliptinEli LillyPhase 3
77
Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Eli LillyApproved
85
teplizumab or placeboEli LillyPhase 1
33
LY2428757 + PlaceboEli LillyPhase 2
52
Insulin Efsitora Alfa + Insulin DegludecEli LillyPhase 3
77
LY900014 (SC) + LY900014 (IV)Eli LillyPhase 1
33

Other Products from Gulf Pharmaceutical Industries

Julphar Insulin N (human isophane insulin) + Huminsulin® Basal (NPH, human isophane insulin)Phase 1
25
human biphasic insulin + human biphasic insulin, referencePhase 1
25